These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8851652)

  • 1. Venlafaxine in the treatment of borderline personality disorder.
    Markovitz PJ; Wagner SC
    Psychopharmacol Bull; 1995; 31(4):773-7. PubMed ID: 8851652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venlafaxine in social phobia.
    Kelsey JE
    Psychopharmacol Bull; 1995; 31(4):767-71. PubMed ID: 8851651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine trial in borderline personality disorder.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    Psychopharmacol Bull; 1990; 26(1):151-4. PubMed ID: 2371370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary trial of fluoxetine in refractory borderline patients.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    J Clin Psychopharmacol; 1991 Apr; 11(2):116-20. PubMed ID: 2056138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of borderline personality disorder.
    Hirschfeld RM
    J Clin Psychiatry; 1997; 58 Suppl 14():48-52; discussion 53. PubMed ID: 9418746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
    J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label trial of venlafaxine in adults with attention deficit disorder.
    Adler LA; Resnick S; Kunz M; Devinsky O
    Psychopharmacol Bull; 1995; 31(4):785-8. PubMed ID: 8851654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose venlafaxine treatment in panic disorder.
    Papp LA; Sinha SS; Martinez JM; Coplan JD; Amchin J; Gorman JM
    Psychopharmacol Bull; 1998; 34(2):207-9. PubMed ID: 9641002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study.
    Pollack MH; Worthington JJ; Otto MW; Maki KM; Smoller JW; Manfro GG; Rudolph R; Rosenbaum JF
    Psychopharmacol Bull; 1996; 32(4):667-70. PubMed ID: 8993089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder.
    Hedges D; Reimherr FW; Rogers A; Strong R; Wender PH
    Psychopharmacol Bull; 1995; 31(4):779-83. PubMed ID: 8851653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine: new preparation. Just another antidepressant.
    Prescrire Int; 1998 Aug; 7(36):112-4. PubMed ID: 10342950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Symptom-focussed drug therapy in borderline personality disorder].
    Schmahl C; Bohus M
    Fortschr Neurol Psychiatr; 2001 Jul; 69(7):310-21. PubMed ID: 11488246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].
    Chabrol H; Chouicha K; Montovany A; Callahan S
    Encephale; 2001; 27(2):120-7. PubMed ID: 11407263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
    Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.
    Sheehan DV
    J Clin Psychiatry; 1999; 60 Suppl 22():23-8. PubMed ID: 10634352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benztropine for venlafaxine-induced night sweats.
    Pierre JM; Guze BH
    J Clin Psychopharmacol; 2000 Apr; 20(2):269. PubMed ID: 10770471
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of affective instability and UPPS impulsivity in borderline personality disorder features.
    Tragesser SL; Robinson RJ
    J Pers Disord; 2009 Aug; 23(4):370-83. PubMed ID: 19663657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashia M; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):150-4. PubMed ID: 17765378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.